Researchers have been excited about the medication , a groundbreaking dual agonist showing significant outcomes in early trials for size loss . It works by impacting both pathways : GLP-1 and GIP, https://alexiahinv216225.bligblogging.com/41469054/this-new-prospect-for-body-loss